Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryReferences
- Xenotransplantation.Br J Surg. 2000; 87: 138-148
- Xenotransplantation—state of the art—update 1999.Front Biosci. 1999; 4: D416-D432
- Xenotransplantation [see comments].Can J Surg. 1999; 42: 12-16
- Xenotransplantation: steps towards a clinical reality.Immunol Today. 1998; 19: 206-208
- The case for using pigs.Bull World Health Organ. 1999; 77: 67-68
- Xenotransplantation: recent progress and current perspectives.Curr Opin Immunol. 1996; 8: 721-728
- The humoral response to xenografts is controlled by a restricted repertoire of immunoglobulin VH genes.Transplantation. 1998; 66: 1375-1383
- Genetic engineering for xenotransplantation.Transplant Proc. 1999; 31: 1488-1490
- Progress in transgenic pigs for xenotransplantation.Liver Transpl Surg. 1998; 4: 150-151
- Factors in xenograft rejection.Ann N Y Acad Sci. 1999; 875: 261-276
- Human CD4+ T cells mediate rejection of porcine xenografts.J Immunol. 1999; 162: 5256-5262
- Role of endothelial apoptosis in delayed xenograft rejection in pig-to-baboon cardiac transplantation.Transplant Proc. 1999; 31: 2731-2732
- Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins.Transplantation. 1999; 67: 467-474
- Bel-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.J Clin Invest. 1999; 103: 543-553
- A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis.Blood. 1998; 91: 2249-2258
- The role of atypical T cells and NK cells in inhibiting primary engraftment of xenogeneic donor rat bone marrow cells.Transplant Proc. 1999; 31: 683
- Normal development in porcine thymus grafts and specific tolerance of human T cells to porcine donor MHC.J Immunol. 1999; 162: 3402-3407
- Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat—>mouse bone marrow chimeras.Transplantation. 1998; 65: 1216-1224
- Zoonosis in xenotransplantation.Curr Opin Immunol. 1998; 10: 539-542
- Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue [see comments].Science. 1999; 285: 1236-1241
- Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboons.Transplant Proc. 1999; 31: 913-914
- Nat Med. 1999; 5: 465
- Nature. 1999; 398: 543
- Nature. 1999; 397: 279
- Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease.Nat Med. 1997; 3: 350-353
- Xenotransplantatian in Sweden.Bull World Health Organ. 1999; 77: 75-76
- Pig-to-human islet transplantation.Transplant Proc. 1998; 30: 3809-3810
- Successful application of extracorporeal liver perfusion: a technology whose time has come.Am J Gastroenterol. 1993; 88: 1876-1881
- Transgenic hDAF pigs livers perfused ex-vivo with human blood have superior function and no evidence of hyperacute rejection compared to wild-type livers [abstract].in: The 5th International Congress of Xenotransplantation, October 1999, Kyoto1999
- Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus.Transplantation. 2000; 69: 272-280
- Xenotransplantation.Annu Rev Med. 1995; 46: 345-360
- Renal heterotransplantation from nonhuman primates to man.Ann N Y Acad Sci. 1969; 162: 412-418
- Baboon-to-human cardiac xenotransplantation in a neonate.JAMA. 1985; 254: 3321-3329
- Baboon-to-human liver transplantation [see comments].Lancet. 1993; 341: 65-71
Article info
Publication history
Footnotes
☆Reprint requests: David Grant, Toronto General Hospital, 621 University Ave, NU-10-114, Toronto, ON M5G-2c4, Canada.
☆☆Surgery 2001;129:243-7.
★*Dr Levy and Dr Grant are executive officers in Transplantation Technologies, Inc, Toronto, Canada, a private biotechnology company that is studying the problems associated with xenografting.